|
Sodium Polystyrene SulfonateDrug - Sodium Polystyrene Sulfonate The trade name of the product as shown on the labeling.
Dosage -
SUSPENSION; ORAL, RECTAL
Active Ingredient(s) -
Sodium Polystyrene Sulfonate
Strength -
15GM/60ML
Applicant -
ROXANE
New Drug Application (NDA) Number -
088453
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Nov 17, 1983
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Roxane Laboratories Inc
Sodium Polystyrene Sulfonate
Sodium Polystyrene Sulfonate 15gm/60ml Suspension; Oral, Rectal
Sodium Phosphates In Plastic Container 142mg/ml;276mg/ml Injectable; Injection Phosphotope 1-8mci/vial Solution; Injection, Oral Sodium Phosphate P 32 0.67mci/ml Solution; Injection, Oral Sodium Phosphate P 32 1.5mci/vial Solution; Injection, Oral Kayexalate 453.6gm/bot Powder; Oral, Rectal Kionex 454gm/bot Powder; Oral, Rectal Sodium Polystyrene Sulfonate 454gm/bot Powder; Oral, Rectal Sodium Polystyrene Sulfonate 453.6gm/bot Powder; Oral, Rectal Sodium Polystyrene Sulfonate 15gm/60ml Suspension; Oral, Rectal NewDrugInformation |